Zobrazeno 1 - 10
of 29
pro vyhledávání: '"G Creemers"'
Autor:
Rebecca V. Steenaard, Richard A. Feelders, Fadime Dogan, Peter M. van Koetsveld, Sara G. Creemers, Madeleine H. T. Ettaieb, Folkert J. van Kemenade, Harm R. Haak, Leo J. Hofland
Publikováno v:
Biomedicines, Vol 11, Iss 7, p 2013 (2023)
The differentiation between benign and malignant adrenocortical tumors based on pathological assessment can be difficult. We present a series of 17 patients with unclear malignant tumors, of whom six had recurrent or metastatic disease. The assessmen
Externí odkaz:
https://doaj.org/article/8dd6353959154a04a0b15c6b72a9d90b
Autor:
Eva E. Schippers, Sara G. Creemers, Sunita Paltansing, Henk C. T. van Zaanen, Joyce A. M. Heijneman
Publikováno v:
SN Comprehensive Clinical Medicine. 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f16da304c2f99f7deb6b1156c7667f9
https://doi.org/10.1007/s42399-022-01232-y
https://doi.org/10.1007/s42399-022-01232-y
Autor:
S G, Creemers, B, Van Santvoort, F W P J, van den Berkmortel, L A, Kiemeney, I M, van Oort, K K H, Aben, P, Hamberg
Publikováno v:
Prostate cancer and prostatic diseases.
The recommended treatment for a subset of patients with metastatic prostate cancer (mPC) changed from androgen deprivation therapy (ADT) to combinations with chemotherapy such as docetaxel. Implementation of new evidence from trials is however comple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c4baba1651710c28cd3e5900be5be56f
https://pubmed.ncbi.nlm.nih.gov/35798856
https://pubmed.ncbi.nlm.nih.gov/35798856
Autor:
B Eyck, J Lanschot, M Hulshof, B Wilk, J Shapiro, P Hagen, D Nieboer, M Berge Henegouwen, B Wijnhoven, H Laarhoven, G Nieuwenhuijzen, G Hospers, J Bonenkamp, M Cuesta, R Blaisse, O Busch, F Kate, G Creemers, C Punt, J Plukker, H Verheul, E Spillenaar Bilgen, H Dekken, M Sangen, T Rozema, K Biermann, J Beukema, A Piet, C Rij, J Reinders, H Tilanus, A Gaast
Publikováno v:
Diseases of the Esophagus. 33
Neoadjuvant chemoradiotherapy according to the Dutch randomised controlled ChemoRadiotherapy for Oesophageal cancer followed by Surgery Study (CROSS) has become standard of care for patients with cancer of the oesophagus or oesophagogastric junction.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a392a937ed08f899e2810596d61ab4d9
https://doi.org/10.1093/dote/doaa087.56
https://doi.org/10.1093/dote/doaa087.56
Autor:
Leo J. Hofland, Gaston J H Franssen, Yolanda B. de Rijke, Frank H. de Jong, Richard A Feelders, Sara G Creemers, Peter M. van Koetsveld
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 106(4), E1618-E1630. Endocrine Society
Introduction Racemic ketoconazole (RK) is a steroidogenesis inhibitor used for treatment of Cushing’s syndrome. Levoketoconazole (COR-003), the pure 2S,4R enantiomer, is potentially more potent and safe compared to RK. We compared in vitro effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7346fe19282970a7a4c7e4c5ce634051
https://pubmed.ncbi.nlm.nih.gov/33399817
https://pubmed.ncbi.nlm.nih.gov/33399817
Autor:
Leo J. Hofland, Michaela Luconi, Harm R. Haak, F. J. van Kemenade, Marco Volante, Michiel N. Kerstens, Massimo Mannelli, Gabriella Nesi, Sara G Creemers, Madeleine H.T. Ettaieb, Martin Fassnacht, Nuria Valdés, Richard A Feelders, Cristina L Ronchi, Mauro Papotti, B. M. van Hemel, María-Dolores Chiara
Publikováno v:
Endocrine-Related Cancer, 27(10), 541-550. Bioscientifica Ltd
Endocrine-Related cancer, 27(10), 541-550. BIOSCIENTIFICA LTD
Endocrine-Related cancer, 27(10), 541-550. BIOSCIENTIFICA LTD
Adrenocortical carcinoma (ACC) is diagnosed using the histopathological Weiss score (WS), but remains clinically elusive unless it has metastasized or grows locally invasive. Previously, we proposed the objective IGF2 methylation score as diagnostic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7502d34f0344d90d817def726b43c582
https://pure.eur.nl/en/publications/b808411b-1001-427c-9665-d731f966e257
https://pure.eur.nl/en/publications/b808411b-1001-427c-9665-d731f966e257
Autor:
Leo J. Hofland, Richard A Feelders, Folkert J. van Kemenade, Tessa M van Ginhoven, Sara G Creemers, Charlotte Lauren Viëtor
Publikováno v:
Cancers, Vol 13, Iss 4383, p 4383 (2021)
Cancers
Cancers
Simple Summary Adrenocortical carcinoma is a rare cancer with a poor prognosis. Adrenal tumors are, however, commonly identified in clinical practice. Discrimination between benign and malignant adrenal tumors is of great importance to determine the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c1ca4fbaef98ddf8ef3e94c35ac43c8
https://doi.org/10.3390/cancers13174383
https://doi.org/10.3390/cancers13174383
Autor:
Gaston J H Franssen, W. W. de Herder, P. M. van Koetsveld, Richard A Feelders, Leo J. Hofland, Sara G Creemers, E. S. R. van den Dungen, Esther Korpershoek, F.J. van Kemenade
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
Journal of Clinical Endocrinology and Metabolism, 101(12), 4574-4584. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 101(12), 4574-4584. Endocrine Society
Context: Treatment of patients with adrenocortical carcinomas (ACC) with mitotane and/or chemotherapy is often associated with toxicity and poor tumor response. New therapeutic options are urgently needed. Objective: The objectives of the study were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0451414569db8a4ed9f6177e4026be32
https://doi.org/10.1210/jc.2016-2768
https://doi.org/10.1210/jc.2016-2768
Autor:
Peter M. van Koetsveld, Leo J. Hofland, Richard A Feelders, Sara G Creemers, Gaston J H Franssen, Yolanda B. de Rijke, Frank H. de Jong
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 104(8), 3437-3449. Endocrine Society
__Context:__ Metyrapone and ketoconazole, frequently used steroidogenesis inhibitors for treatment of Cushing's syndrome, can be associated with side effects and limited efficacy. Osilodrostat is a CYP11B1 and CYP11B2 inhibitor, with unknown effects
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e720238b401282b05d80ded761efb00
https://pubmed.ncbi.nlm.nih.gov/31127821
https://pubmed.ncbi.nlm.nih.gov/31127821
Autor:
Fadime Dogan, W. W. de Herder, Leo J. Hofland, Sara G Creemers, Gaston J H Franssen, Richard A Feelders, P. M. van Koetsveld
Publikováno v:
Endocrine-Related Cancer, 26(3), 367-378. Bioscientifica Ltd
Chemotherapy for adrenocortical carcinoma (ACC) has limited efficacy and is accompanied by severe toxicity. This lack of effectiveness has been associated with high tumoral levels of the multidrug resistance (MDR) pump P-glycoprotein (P-gp), encoded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::229d49ad0ee5336b28d404275adf3387
https://pure.eur.nl/en/publications/80b8f473-0652-4929-8a28-9f711173918a
https://pure.eur.nl/en/publications/80b8f473-0652-4929-8a28-9f711173918a